Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
DLL3 overexpression
i
Other names:
DLL3, Delta Like Canonical Notch Ligand 3, Drosophila Delta Homolog 3, Delta-Like Protein 3, Delta3, Delta (Drosophila)-Like 3, Delta-Like 3 (Drosophila), Delta-Like 3, SCDO1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
10683
Related biomarkers:
Expression
‹
›
Associations
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
DLL3 overexpression
Small Cell Lung Cancer
DLL3 overexpression
Small Cell Lung Cancer
PD-L1 inhibitor
Resistant: C3 – Early Trials
ASCO 2023 - 4 days (New C3)
PD-L1 inhibitor
Resistant
:
C3
ASCO 2023 - 4d
PD-L1 inhibitor
Resistant: C3 – Early Trials
ASCO 2023 - 4 days
PD-L1 inhibitor
Resistant
:
C3
ASCO 2023 - 4 days - (New C3)
DLL3 overexpression
Neuroendocrine Tumor
DLL3 overexpression
Neuroendocrine Tumor
rovalpituzumab tesirine
Sensitive: C2 – Inclusion Criteria
rovalpituzumab tesirine
Sensitive
:
C2
rovalpituzumab tesirine
Sensitive: C2 – Inclusion Criteria
rovalpituzumab tesirine
Sensitive
:
C2
DLL3 overexpression
Small Cell Lung Cancer
DLL3 overexpression
Small Cell Lung Cancer
rovalpituzumab tesirine
Sensitive: C2 – Inclusion Criteria
rovalpituzumab tesirine
Sensitive
:
C2
rovalpituzumab tesirine
Sensitive: C2 – Inclusion Criteria
rovalpituzumab tesirine
Sensitive
:
C2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login